Maria Barrera,
Clayful
Scale the Bright Spots
Startups can address important mental health problems, but maintaining mental health in startup culture is challenging.
Stanford professor Russ Altman emphasizes that AI is opening new opportunities to understand how medicines interact with specific proteins, and build more highly customized therapies. He points to DeepMind’s AlphaFold 2 deep learning system as a particularly powerful new tool for re-envisioning how drugs are discovered and designed.
